Follow The Filings

CGON CG Oncology

CG Oncology earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 13 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by CGON's executives, directors and 10% owners in the last 12 months, from their Form 4s

All CGON insider trades
  • $24.8M bought by 1 insider
  • None no sales outside a trading plan
  • $4.8M sold by 2 insiders under 10b5-1 plans
  1. Leonard E Post Director
    Planned sale
    $62K 1,000 shares at $62.07 100% of stake
    Traded Oct 15 Filed Oct 19
    ↗
  2. Leonard E Post Director
    Planned sale
    $73K 1,000 shares at $72.98 100% of stake
    Traded Sep 15 Filed Sep 17
    ↗
  3. Leonard E Post Director
    Planned sale
    $75K 1,000 shares at $74.54 100% of stake
    Traded Aug 14 Filed Aug 18
    ↗
  4. Leonard E Post Director
    Planned sale
    $71K 1,000 shares at $71.17 100% of stake
    Traded Jul 15 Filed Jul 17
    ↗
  5. James Mulay Director
    Planned sale
    $1.8M 24,165 shares at $75.16 100% of stake
    Traded Jul 10 Filed Jul 14
    ↗
  6. Brian Guan-Chyun Liu Director
    Buy
    $24.8M 371,085 shares at $66.87 +25% to stake
    Traded Jun 25 Filed Jun 29
    ↗
  7. Leonard E Post Director
    Planned sale
    $350K 5,000 shares at $70.00 100% of stake
    Traded Jun 24 Filed Jun 25
    ↗
  8. Leonard E Post Director
    Planned sale
    $325K 5,000 shares at $65.00 100% of stake
    Traded Jun 22 Filed Jun 23
    ↗
  9. James Mulay Director
    Planned sale
    $118K 1,964 shares at $60.12 100% of stake
    Traded Jun 15 Filed Jun 16
    ↗
  10. Leonard E Post Director
    Planned sale
    $55K 1,000 shares at $54.50 100% of stake
    Traded Jun 4 Filed Jun 5
    ↗
  11. James Mulay Director
    Planned sale
    $1.1M 15,600 shares at $73.01 100% of stake
    Traded Apr 17 Filed Apr 20
    ↗
  12. James Mulay Director
    Planned sale
    $125K 1,964 shares at $63.50 100% of stake
    Traded Mar 16 Filed Mar 17
    ↗
  13. James Mulay Director
    Planned sale
    $585K 11,145 shares at $52.47 100% of stake
    Traded Jan 9 Filed Jan 13
    ↗
  14. Leonard E Post Director
    Planned sale
    $41K 1,000 shares at $41.43 100% of stake
    Traded Nov 17, 2025 Filed Nov 18, 2025
    ↗
  15. Leonard E Post Director
    Planned sale
    $43K 1,000 shares at $43.25 100% of stake
    Traded Oct 13, 2025 Filed Oct 15, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 18 option exercises and 2 share withholdings for taxes.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
424B5 Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 5.07 Filing Doc
8-K 5.02 Filing Doc
SCHEDULE 13G — Filing Doc
SCHEDULE 13G — Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13G/A — Filing Doc

Source: SEC EDGAR submissions, updated 4 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.